Wird geladen...
Myasthenia Gravis Induced by Ipilimumab in a Patient With Metastatic Melanoma
In daily clinical practice, there is a growing number of patients receiving new biological agents used in the treatment of malignancies. Ipilimumab is a fully humanized monoclonal antibody approved for patients with melanoma. It acts as an immune checkpoint inhibitor, binding and blocking cytotoxic...
Gespeichert in:
| Veröffentlicht in: | Front Neurol |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5891586/ https://ncbi.nlm.nih.gov/pubmed/29666602 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2018.00150 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|